Imidazole and thiazole compositions for modifying biological signaling

Patent metadata

Field	Value
Publication number	US-10633377-B2
Application number	US-201916521925-A
Country	US
Kind code	B2
Filing date	Jul 25, 2019
Priority date	Jul 18, 2014
Publication date	Apr 28, 2020
Grant date	Apr 28, 2020

Abstract

Compounds having General Formula (I) or General Formula (II):

in which R 1 is chosen from C 1 to C 10 aliphatic or heteroaliphatic groups, optionally substituted with one or more aryl groups, substituted aryl groups, heteroaryl groups, substituted heteroaryl groups, or combination thereof, R 2 is chosen from aromatic moieties, substituted aromatic moieties, heteroaromatic moieties, substituted heteroaromatic moieties, and coumarin; R 3 is chosen from —H, C 1 to C 10 aliphatic or heteroaliphatic groups, phenyl, or substituted phenyl, wherein the aliphatic or heteroaliphatic groups are optionally substituted with one or more phenyl groups, aryl groups, heteroaryl groups, substituted heteroaryl groups, or combination thereof, and wherein the aliphatic or heteroaliphatic groups are optionally bonded to R 2 to form a ring; X is S or O; and Y is S or NH, may be used in pharmaceutical compositions that modify of biological signaling processes or as reagents for biological assays.

First claim

What is claimed is:

1. A composition comprising at least one compound or a pharmaceutically-acceptable salt thereof, wherein the at least one compound is selected from the group consisting of COB-168, COB-206, COB-201, DRB-3, COB-190, GWB-93, Z-01, Z-02, Z-03, Z-04, Z-05, Z-10, COB-161, COB-193, COB-186, COB-124, and COB-125, according to the following structures:

2. The composition of claim 1 , wherein the at least one compound is selected from the group consisting of COB-168, COB-206, and COB-201.

3. The composition of claim 2 , wherein the at least one compound is COB-168.

4. The composition of claim 2 , wherein the at least one compound is COB-206.

5. The composition of claim 2 , wherein the at least one compound is COB-201.

6. The composition of claim 1 , wherein the at least one compound is DRB-3.

7. The composition of claim 1 , wherein the at least one compound is COB-190.

8. The composition of claim 1 , wherein the at least one compound is selected from the group consisting of GWB-93, Z-01, Z-02, Z-03, Z-04, Z-05, and Z-10.

9. The composition of claim 8 , wherein the at least one compound is GWB-93.

10. The composition of claim 8 , wherein the at least one compound is Z-01.

11. The composition of claim 8 , wherein the at least one compound is Z-02.

12. The composition of claim 8 , wherein the at least one compound is Z-03.

13. The composition of claim 8 , wherein the at least one compound is Z-04.

14. The composition of claim 8 , wherein the at least one compound is Z-05.

15. The composition of claim 8 , wherein the at least one compound is Z-10.

16. The composition of claim 1 , wherein the at least one compound is COB-161.

17. The composition of claim 1 , wherein the at least one compound is COB-193.

18. The composition of claim 1 , wherein the at least one compound is COB-186.

19. The composition of claim 1 , wherein the at least one compound is COB-124.

20. The composition of claim 1 , wherein the at least one compound is COB-125.

Assignees

• Univ Ohio

Inventors

• Goetz Douglas
• Bergmeier Stephen C
• Mcmills Mark C
• Orac Crina M

Classifications

• C07D277/16

  Sulfur atoms · CPC title

• A61P33/00

  Antiparasitic agents · CPC title

• C07D413/04

  directly linked by a ring-member-to-ring-member bond · CPC title

• A61K31/428

  condensed with carbocyclic rings · CPC title

• C07D277/36

  Sulfur atoms · CPC title